Lecuire F, Collodel M, Basso M, Rubini J, Gontier D, Carrère J
Service de chirurgie orthopédique, Hôpital Renée Sabran, Giens.
Rev Chir Orthop Reparatrice Appar Mot. 1999 Jul;85(4):337-48.
57 cases of infected total hip prosthesis treated by removal of the implant and implantation of unncemented prosthesis, were studied to evaluate functional and sepsis results.
57 patients treated by reimplantation of an uncemented total hip prosthesis after removal of the infected prosthesis were observed. 16 patients underwent a single-stage exchange, 41 a two-stage reimplantation. 46 cases were analysed for infection findings (clinical, radiological and biological assessment) and only 34 cases for functional evaluation (PMA scale, Harris score) with a mean follow-up of 6.6 years. The antibiotic therapy was adapted to each patient but generally, the treatment was prolonged.
At follow-up time (which might be too short in time), only 2 patients had a recurrence of infection. One had a single-stage exchange (reoperated by two stage exchange with a good final result at 6 years follow-up), the other a two-stage exchange. In both cases we found that postoperative antibiotic therapy was inadequate. Functional results were better with PMA scale (23 good results of 34) than with Harris score (14 excellent or good results only). 5 patients were reoperated for mechanical implant failure.
Since 1991, we adopted a standardized procedure to treat chronic infected total hip prosthesis including: routine preoperative aspiration of symptomatic prosthesis; removal of the implant and around debridement followed at a later date (6 weeks) by reimplantation using uncemented implants (hydroxyapatite coated implant). Postoperative antibiotic therapy has to be massive (parenteral bitherapy for at least 21 days after each operative stage) and has to last 6 months after reimplantation. This procedure seems reliable and corroborate the validity of two-stage treatment. The using of uncemented implants allows a good bone reconstruction and does not seem to increase the risk of septic recurrence.
It is quite difficult to find a hard and fast rule in infected prosthesis treatment, because many factors can influence results. The proposed procedure seems reliable, even if antibiotherapy is long and hard, but requires a strong collaboration between bacteriologist infectiologist and surgeon.
对57例因感染而进行假体取出并植入非骨水泥型假体治疗的全髋关节置换病例进行研究,以评估其功能及感染控制效果。
观察57例在感染性假体取出后重新植入非骨水泥型全髋关节假体的患者。16例患者接受一期置换,41例接受二期再植入。对46例患者进行了感染情况分析(临床、影像学及生物学评估),仅对34例患者进行了功能评估(采用PMA量表、Harris评分),平均随访6.6年。抗生素治疗根据每位患者的情况进行调整,但总体而言治疗时间延长。
在随访时(时间可能较短),仅2例患者感染复发。1例接受一期置换(后通过二期置换再次手术,6年随访时最终结果良好),另1例接受二期置换。在这两例中,我们发现术后抗生素治疗不足。采用PMA量表评估的功能结果(34例中有23例结果良好)优于采用Harris评分评估的结果(仅14例为优或良)。5例患者因机械性植入物失败而再次手术。
自1991年以来,我们采用标准化程序治疗慢性感染性全髋关节假体,包括:对有症状的假体进行术前常规穿刺抽吸;取出植入物并进行周围清创,随后(6周后)使用非骨水泥型植入物(羟基磷灰石涂层植入物)进行再植入。术后抗生素治疗必须足量(每个手术阶段后至少21天进行胃肠外联合治疗),并在再植入后持续6个月。该程序似乎可靠,证实了两阶段治疗的有效性。使用非骨水泥型植入物可实现良好的骨重建,且似乎不会增加感染复发的风险。
在感染性假体治疗中很难找到一条固定不变的规则,因为许多因素会影响治疗结果。所提出的程序似乎可靠,尽管抗生素治疗时间长且难度大,但需要细菌学家、感染病学家和外科医生之间密切协作。